Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04626908. IPD Sharing: NO. Countries: 1. Publications: 0.
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
ClinicalTrials.gov study NCT06206902. IPD Sharing: NO. Countries: 1. Publications: 0.
phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT00496431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
ClinicalTrials.gov study NCT00364676. IPD Sharing: Not stated. Countries: 2. Publications: 0.
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT04028440. IPD Sharing: NO. Countries: 1. Publications: 0.
APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05186012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Comb
ClinicalTrials.gov study NCT01209130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemot
ClinicalTrials.gov study NCT00185393. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.
ClinicalTrials.gov study NCT02227433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
ClinicalTrials.gov study NCT06784167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.
ClinicalTrials.gov study NCT04697290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02168907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT02723071. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT03302728. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03343652. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00098566. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00549185. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06859008. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.